Questions about Myasthenia Gravis
Which specific antibodies must be present for Epysqli approval in myasthenia gravis?
Epysqli (eculizumab-sbja) is FDA-approved for generalized myasthenia gravis only in adult patients who test positive for anti-acetylcholine receptor (AChR) antibodies.
Full answer →Can thymoma be associated with myasthenia gravis and stiff person syndrome?
Yes, thymoma can be associated with both myasthenia gravis and stiff person syndrome, though this combination is very rare.
Full answer →Do complement inhibitors improve outcomes for myasthenia gravis patients?
Yes, complement inhibitors (eculizumab, ravulizumab, zilucoplan) significantly improve symptoms and daily functioning in AChR antibody-positive generalized myasthenia gravis, based on multiple trials and real-world studies.
Full answer →Is there a link between myasthenia gravis and the risk of autoimmune encephalitis?
Yes, people with myasthenia gravis have an increased risk of developing autoimmune encephalitis, likely due to shared autoimmune mechanisms and overlapping antibody targets.
Full answer →Can a ketogenic diet improve quality of life for myasthenia gravis adults?
Early research suggests a ketogenic diet may improve symptoms and quality of life in myasthenia gravis, but evidence is limited to one small pilot study.
Full answer →Does efgartigimod help improve symptoms for myasthenia gravis patients?
Yes, efgartigimod helps improve symptoms in myasthenia gravis patients, with most studies showing clinically meaningful improvements in daily living scores and muscle strength.
Full answer →